Načítá se...
Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma
Background: Hepatocellular carcinoma (HCC) is one of the most prevalent fatal cancers in the world. Despite advances in early diagnosis and improvements in surgical techniques, the survival of patients with HCC even after resection is poor because of the high incidence of recurrences. Therefore, the...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Copyright 2005 Journal of Clinical Pathology
2005
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1770655/ https://ncbi.nlm.nih.gov/pubmed/15858121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jcp.2004.023556 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|